Funder
Sanofi Genzyme
Top Consortia for Knowledge and Innovation
Reference21 articles.
1. Natural variability in the disease course of SSc-ILD: implications for treatment;Vonk;European Respiratory Review [Internet],2021
2. Predictors of progression in systemic sclerosis patients with interstitial lung disease;Distler;European Respiratory Journal [Internet],2020
3. Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis;Tiev;European Respiratory Journal [Internet],2011
4. Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis;Schupp;European Respiratory Journal [Internet],2014
5. Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis;De Lauretis;J. Rheumatol.,2013